SRTS — Sensus Healthcare, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1494891 ·
Last close
$2.26
Market Cap
$37.20M
52W High
$5.49
52W Low
$2.14
ADV30
396,626
Next earnings
2027-02-11
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 5,995,000 3,288,000 -1,619,000 -1,493,000 40,551,000 12,920,000 5,111,000
Jun 2026 2,290,000 769,000 -3,180,000 -8,749,000 41,259,000 15,186,000 4,396,000
Mar 2026 3,394,000 991,000 -4,358,000 -2,626,000 51,546,000 18,327,000 6,004,000
Dec 2025 4,939,000 1,897,000 -3,148,000 -3,167,000 53,039,000 22,083,000 4,941,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,798,000
Investing CF
$-173,000
Financing CF
$-5,000
CapEx
$-173,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.94
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-5,660,000
Inventory
$18,459,000
Receivables
$1,680,000
ST Investments
—
EBIT TTM
$-13,255,000
Pretax Income TTM
$-12,698,000
Interest Exp TTM
—
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$17,507,000
EBITDA
$-12,872,000
Free Cash Flow
$-2,082,375
Enterprise Value
$38,164,828
Total Cash
$15,186,000
Total Debt
$343,000
Shares Out
16,462,059
Trailing EPS
$-0.97
Book Value
$2.92
ROE
-34.8%
ROA
-16.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 27,482,000 -10,307,000 -7,719,000 53,039,000 4,941,000 48,098,000 528,000
Dec 2024 41,807,000 8,090,000 6,647,000 62,165,000 6,338,000 55,827,000 -831,000
Dec 2023 24,405,000 -382,000 485,000 53,710,000 4,868,000 48,842,000 -2,145,000
Dec 2022 44,532,000 14,831,000 24,244,000 56,735,000 8,666,000 48,069,000 -1,412,000

TTM Snapshot

Revenues TTM
$17,507,000
NetIncome TTM
$-15,485,000
OpCashFlow TTM
—
Assets (Latest)
$41,259,000
Forward EPS
$-0.10

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.00 · spot: $2.30 · call volume: 61 · put volume: 0
Expected Move to 2027-04-16: ±$0.95 (41.30%) — implied range $1.35 – $3.25 · ATM straddle on $2.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
NXGL NEXGEL, INC. $37.04M $3.80 —
MYO MYOMO, INC. $36.85M $0.92 —
ADGM Adagio Medical Holdings, Inc. $36.65M $1.65 —
MCAG Mountain Crest Acquisition Corp. V $38.13M $13.27 —
HRGN Harvard Apparatus Regenerative Technology, Inc. $38.54M $1.90 —

News headlines (Yahoo Finance, 1h cache)

Sensus Healthcare (SRTS) Q3 2026 Earnings Call Transcript
2026-11-13 07:31 · Yahoo
Sensus Healthcare Inc (SRTS) (Q3 2026) Earnings Call Highlights: Margin Expansion and New ...
2026-11-13 05:03 · Yahoo
What Sensus Healthcare (SRTS) Said on Its Q3 Earnings Call
2026-11-13 04:14 · Yahoo
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
2026-11-12 21:05 · Yahoo
Sensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial Milestone
2026-11-10 13:00 · Yahoo
Sensus Healthcare to Report Third Quarter 2026 Financial Results and Hold Business Update Conference Call on November 12, 2026
2026-10-29 20:05 · Yahoo
Sensus (SRTS) Q2 2026 Earnings Call Transcript
2026-08-20 22:45 · Yahoo
Sensus Healthcare Inc (SRTS) (Q2 2026) Earnings Call Highlights: Strong Pipeline and New CPT ...
2026-08-17 19:01 · Yahoo
Sensus Healthcare Q2 Earnings Call Highlights
2026-08-14 03:04 · Yahoo
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
2026-08-13 20:22 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-11-17 16:27:09 2026-11-16 Sardano Joseph C CEO P - Purchase 2.4 30000 72108